APA (7th ed.) Citation

A, Y., AA, O., A, S., D, K., T, R., & R, Y. (2013). Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients. Dove Medical Press.

Chicago Style (17th ed.) Citation

A, Yamamoto, Okada AA, Sugitani A, Kunita D, Rii T, and Yokota R. Two-year Outcomes of Pro Re Nata Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration in Japanese Patients. Dove Medical Press, 2013.

MLA (8th ed.) Citation

A, Yamamoto, et al. Two-year Outcomes of Pro Re Nata Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration in Japanese Patients. Dove Medical Press, 2013.